Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
dNovo Bio logo — Towards the Cure for Hair Loss

dNovo Bio

Towards the Cure for Hair Loss

Founded 2018 United States San Jose, United States 3 employees Seed Total: $2.70M Biotechnology, Health Care

General Information

Company Name dNovo Bio
Founded Year 2018
Location United States San Jose, United States
Founders / Decision Makers
Team member
Employees 3
Industries Biotechnology, Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with dNovo Bio. To contact dNovo Bio, visit dnovobio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does dNovo Bio compare?

A PDF of dNovo Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting dNovo Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About dNovo Bio

dNovo Bio is a biotechnology startup founded in 2018 in the United States, with a mission encapsulated in its slogan: "Towards the Cure for Hair Loss". The company's groundbreaking approach involves utilizing direct reprogramming technology to address the prevalent issue of hair loss. By leveraging this innovative technology, dNovo Bio can transform skin, blood, or fat into new hair stem cells, offering a potential solution for hair loss attributed to aging. Recently, the company secured a significant milestone with a $2.70M Seed Round investment on 24 January 2022, drawing support from a notable group of investors including Soma Capital, Felicis Ventures, Y Combinator, Pioneer Fund, Ataria, Justin Mateen, Paul Buchheit, Joey Krug, Jason Hodges, and Jean Pigozzi. Positioned at the intersection of the biotechnology and healthcare industries, dNovo Bio exemplifies the potential for impactful innovation in a prominent and pressing global health concern.

Business keywords: hair loss, stem cells, reprogramming technology, skin, blood, fat, regenerative medicine, age-related treatments

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $2.70M 10
Soma Capital Felicis Ventures Y Combinator
Soma Capital, Felicis Ventures +8
24 Jan 2022
Seed Round Undisclosed -
01 Jan 2018

dNovo Bio Alternatives & Competitors

View All Alternatives
dNovo Bio vs
Aptus Bioreactors
Aptus Bioreactors United States

Regenerating Tissues, for Life

3 employees
Biotechnology, Health Care
dNovo Bio vs
Stembio Cell and Tissue Technologies Inc.
Stembio Cell and Tissue Technologies Inc. Turkey

Our purpose is to build a leading, focused ATMPs company powered by advanced therapy platforms and d...

89 employees
Biotechnology, Health Care
dNovo Bio vs
PrimeCell Bioscience, a.s.
PrimeCell Bioscience, a.s. Czech Republic

Měníme klasické paradigma léčby

4 employees
Biotechnology, Health Care
View all alternatives

FAQ About dNovo Bio

Towards the Cure for Hair Loss
dNovo Bio was founded in 2018.
dNovo Bio is headquartered in San Jose, United States.
dNovo Bio operates in Biotechnology and Health Care. Its work centres on hair loss, stem cells, reprogramming technology and skin.
dNovo Bio has approximately 3 employees.
dNovo Bio has completed 2 funding rounds, raising a total of $2.70M. The latest funding stage is Seed.
Top alternatives and competitors to dNovo Bio include Aptus Bioreactors, Stembio Cell and Tissue Technologies Inc., PrimeCell Bioscience, a.s., NewLimit, CORD:USE Cord Blood Bank Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
dNovo Bio and Aptus Bioreactors are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for dNovo Bio, https://bouncewatch.com/company/dnovo-bio, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout